Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Morphine Sulfate Extended-Release Tablets CII 15 mg 30 mg 60 mg 100 mg* 200 mg*
Medication labelWhy this: Advisory · dailymed-prescription
Morphine Sulfate Extended-Release Tablets are an extended-release oral formulation of morphine sulfate indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Morphine Sulfate Extended-Release Tablets are NOT intended for use as a prn analgesic. The Morphine Sulfate Extended-Release Tablets 100 and 200 mg tablet strengths are high dose, extended-release, oral morphine formulations indicated for the relief of pain in opioid-tolerant patients only. Morphine Sulfate Extended-Release Tablets are not indicated for pain in the immediate postoperative period (the first 12-24 hours following surgery) for patients not previously taking the drug, because its safety in this setting has not been established. Morphine Sulfate Extended-Release Tablets are not indicated for pain in the postoperative period if the pain is mild, or not expected to persist for an extended period of time. Morphine Sulfate Extended-Release Tablets are only indicated for postoperative use if the patient is already receiving the drug prior to surgery or if the postoperative pain is expected to be moderate to severe and persist for an extended period of time. Physicians should individualize treatment, moving from parenteral to oral analgesics as appropriate. (see American Pain Society guidelines.)
- generic_name
- morphine sulfate
- product_names
- Morphine Sulfate
- ndc
- 52959-185, 42858-801, 52959-185-30, 52959-185-60, 52959-185-90, 52959-185-02, 52959-406, 42858-802, 52959-406-30, 52959-406-60, 52959-406-90, 52959-406-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en